Literature DB >> 10556941

Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices.

S Latini1, F Bordoni, R Corradetti, G Pepeu, F Pedata.   

Abstract

1. In the present study we investigated the role of A2A adenosine receptors in hippocampal synaptic transmission under in vitro ischaemia-like conditions. 2. The effects of adenosine, of the selective A2A receptor agonist, CGS 21680 (2-[p-(2-carboxyethyl)-phenethylamino]-5'-N-ethylcarboxamidoade nos ine ), and of selective A2A receptor antagonists, ZM 241385 (4-(2-[7-amino-2-(2-furyl)-¿1,2,4¿-triazolo¿2,3-a¿¿1,3, 5¿triazin-5-ylamino]ethyl)phenol) and SCH 58261 (7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2, 4-triazolo[1,5-c]pyrimidine), have been evaluated on the depression of field e.p.s.ps induced by an in vitro ischaemic episode. 3. The application of 2 min of in vitro ischaemia brought about a rapid and reversible depression of field e.p.s.ps, which was completely prevented in the presence of the A1 receptor antagonist DPCPX (1, 3-dipropyl-8-cyclopentylxanthine) (100 nM). On the other hand both A2A receptor antagonists, ZM 241385 and SCH 58261, by themselves did not modify the field e.p.s.ps depression induced by in vitro ischaemia. 4. A prolonged application of either adenosine (100 micronM) or CGS 21680 (30, 100 nM) before the in vitro ischaemic episode, significantly reduced the synaptic depression. These effects were antagonized in the presence of ZM 241385 (100 nM). 5. SCH 58261 (1 and 50 nM) did not antagonize the effect of 30 nM CGS 21680 on the ischaemia-induced depression. 6. These results indicate that in the CA1 area of the hippocampus the stimulation of A2A adenosine receptors attenuates the A1-mediated depression of synaptic transmission induced by in vitro ischaemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556941      PMCID: PMC1571729          DOI: 10.1038/sj.bjp.0702888

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  55 in total

1.  Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.

Authors:  R A Cunha; B Johansson; M D Constantino; A M Sebastião; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

2.  Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum.

Authors:  A K Dixon; L Widdowson; P J Richardson
Journal:  J Neurochem       Date:  1997-07       Impact factor: 5.372

Review 3.  A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system.

Authors:  S Latini; M Pazzagli; G Pepeu; F Pedata
Journal:  Gen Pharmacol       Date:  1996-09

4.  The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.

Authors:  C Zocchi; E Ongini; A Conti; A Monopoli; A Negretti; P G Baraldi; S Dionisotti
Journal:  J Pharmacol Exp Ther       Date:  1996-02       Impact factor: 4.030

5.  Tissue distribution of adenosine receptor mRNAs in the rat.

Authors:  A K Dixon; A K Gubitz; D J Sirinathsinghji; P J Richardson; T C Freeman
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

6.  The selective adenosine A2A receptor antagonist SCH 58261 discriminates between two different binding sites for [3H]-CGS 21680 in the rat brain.

Authors:  K Lindström; E Ongini; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

7.  Adenosine by activating A1 receptors prevents GABAA-mediated actions during hypoxia in the rat hippocampus.

Authors:  R Lucchi; S Latini; A de Mendonça; A M Sebastião; J A Ribeiro
Journal:  Brain Res       Date:  1996-09-02       Impact factor: 3.252

8.  Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats.

Authors:  P Popoli; P Betto; R Reggio; G Ricciarello
Journal:  Eur J Pharmacol       Date:  1995-12-12       Impact factor: 4.432

9.  Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist.

Authors:  D K Von Lubitz; R C Lin; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1995-12-20       Impact factor: 4.432

10.  The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil.

Authors:  J W Phillis
Journal:  Brain Res       Date:  1995-12-24       Impact factor: 3.252

View more
  17 in total

Review 1.  Beneficial and detrimental role of adenosine signaling in diseases and therapy.

Authors:  Hong Liu; Yang Xia
Journal:  J Appl Physiol (1985)       Date:  2015-08-27

2.  Adenosine A(1) receptor: Functional receptor-receptor interactions in the brain.

Authors:  Kathrin Sichardt; Karen Nieber
Journal:  Purinergic Signal       Date:  2007-09-05       Impact factor: 3.765

3.  Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices.

Authors:  Elisabetta Coppi; Anna Maria Pugliese; Holger Stephan; Christa E Müller; Felicita Pedata
Journal:  Purinergic Signal       Date:  2007-01-03       Impact factor: 3.765

Review 4.  Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment.

Authors:  E S Vizi; A Fekete; R Karoly; A Mike
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

5.  Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors.

Authors:  Anna Maria Pugliese; Serena Latini; Renato Corradetti; Felicita Pedata
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

6.  Smoke extract impairs adenosine wound healing: implications of smoke-generated reactive oxygen species.

Authors:  Diane S Allen-Gipson; Matthew C Zimmerman; Hui Zhang; Glenda Castellanos; Jennifer K O'Malley; Horacio Alvarez-Ramirez; Kusum Kharbanda; Joseph H Sisson; Todd A Wyatt
Journal:  Am J Respir Cell Mol Biol       Date:  2013-05       Impact factor: 6.914

7.  The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices.

Authors:  A M Pugliese; C Traini; S Cipriani; M Gianfriddo; T Mello; M G Giovannini; A Galli; F Pedata
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

8.  Binding of the prototypical adenosine A(2A) receptor agonist CGS 21680 to the cerebral cortex of adenosine A(1) and A(2A) receptor knockout mice.

Authors:  Luísa V Lopes; Linda Halldner; Nelson Rebola; Björn Johansson; Catherine Ledent; Jian Fan Chen; Bertil B Fredholm; Rodrigo A Cunha
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

Review 9.  Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction.

Authors:  Nicholas L Weilinger; Valentyna Maslieieva; Jennifer Bialecki; Sarup S Sridharan; Peter L Tang; Roger J Thompson
Journal:  Acta Pharmacol Sin       Date:  2012-08-06       Impact factor: 6.150

10.  AMP N(1)-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase.

Authors:  Noriko Hattori; Hiroshi Nomoto; Hidefumi Fukumitsu; Satoshi Mishima; Shoei Furukawa
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.